According to a new report by Polaris Market Research, the global AI in medical writing market was valued at USD 684.19 million in 2022 and is projected to reach USD 2,072.30 million by 2032, expanding at a CAGR of 12.4% over the forecast period. Growth is underpinned by rising R&D investment among pharmaceutical companies, expanding outsourcing to Contract Research Organizations, and accelerating adoption of AI-driven documentation tools across key end-use industries.

What Is Driving AI in Medical Writing Market Growth?

Demand is climbing as tightening regulatory requirements from bodies such as the FDA and EMA converge with rising R&D spending across the pharmaceutical, medical device, and biotechnology sectors. Companies are prioritizing efficient, AI-assisted documentation, pushing AI in medical writing adoption across clinical trial and regulatory-submission workflows. Polaris analysts note that pharmaceutical companies reporting an 80% reduction in medical-writing turnaround time after adopting AI tools position the segment for sustained double-digit growth through 2032, with pharmaceutical companies emerging as the largest revenue contributor and medical devices posting steady incremental gains.

Key Trends Shaping the AI in Medical Writing Industry

Generative AI for Regulatory Content

Vendors such as Yseop are partnering with global technology integrators to scale generative AI-powered scientific content development, marking a clear technology advancement in how regulatory submissions are drafted.

Tightening Global Regulatory Standards

Rising documentation demands from the FDA and EMA are reshaping the regulatory landscape, pushing pharmaceutical and device makers toward AI tools that can keep pace with evolving compliance requirements.

CRO Outsourcing Growth

An expanding share of pharmaceutical R&D, including medical writing, is being outsourced to Contract Research Organizations, a shift that is reshaping the competitive landscape and creating new integration opportunities for AI writing vendors.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

https://www.polarismarketresearch.com/industry-analysis/ai-in-medical-writing-market 

Market Segmentation: Breaking Down the AI in Medical Writing Market

Polaris segments the AI in medical writing market by type, end use, and region, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Type

The type writing segment accounted for the largest share of the market in 2022, reflecting its central role in compiling and reporting statistical data from clinical trials for regulatory submissions and post-approval documentation. The clinical writing segment is projected to register the fastest growth rate through 2032, driven by rising clinical trial volumes and the need for accurate, well-structured documentation from writers with deep clinical-field expertise.

By End Use

The pharmaceutical segment is projected to hold significant market share, as drug developers accumulate extensive clinical trial, pre-clinical, and scientific-literature data that serves as training material for AI writing models — and as AI adoption cuts medical-writing turnaround time by as much as 80% for some companies. The medical devices segment is witnessing steady growth as Natural Language Processing tools increasingly automate literature review, data extraction, and research summarization tasks.

Regional Outlook: Where Is AI in Medical Writing Growing Fastest?

North America dominated the market in 2022, led by U.S. demand tied to FDA clearance requirements that call for precise, compliance-ready clinical documentation. Asia Pacific is expected to emerge as the fastest-growing region, driven by rising healthcare expenditure and rapid AI-technology advancement in China, Japan, South Korea, and India. Within North America, the U.S. remains the largest single market; within Asia Pacific, China and India are the primary growth engines as AI-powered medical writing tools gain regional traction.

Competitive Landscape: Leading AI in Medical Writing Companies

Key players profiled in the report are focusing on partnerships, product upgrades, and collaboration to strengthen market position across the type writing and pharmaceutical segments outlined above. Recent moves include Yseop and Cognizant's 2024 collaboration to scale generative AI-powered biopharma content development and Sanofi's partnership with Yseop to automate safety-report generation, both aimed at deepening share in regulated documentation workflows.

Some of the key players profiled in the report include:

• Parexel International
• Trilogy Writing & Consulting
• Freyr
• Cactus Communications
• GENINVO

Why It Matters for Buyers Evaluating AI Medical Writing Market Entry

For stakeholders researching AI-driven regulatory documentation, this report benchmarks market share, segment-level pricing, and forecast data — by type, end use, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing AI medical-writing vendors, investors sizing entry points, and strategy teams tracking medical devices as a growth adjacency.

About Polaris Market Research

Polaris Market Research is a B2B syndicated market research and consulting firm offering 5,000+ published reports across 20+ industry verticals, delivering data-backed insights to help businesses make informed decisions.

More Trending Latest Reports By Polaris Market Research:

sustainability-as-a-business-driver-how-of-consumers-now-influence-market-strategies

benchmarking-performance-of-the-top-20-companies-in-the-livestock-monitoring-market-in-2025

germanium-market

fruit-and-vegetable-wash-market

biofabrication-market

hydrochloric-acid-market

micro-mobility-market

industrial-hose-market

policosanol-market